Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis
International Journal of Radiation Oncology*Biology*Physics · 2025-02 · 121 (2) · 432-441
DOI: 10.1016/j.ijrobp.2024.09.022 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025-02. Verfasst von Young Seob Shin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology. Hauptthemen laut MEDLINE: Radiosurgery, Liver Neoplasms, Carcinoma, Hepatocellular, Metastasectomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
PURPOSE: Although there is a growing role for local therapy in patients with hepatocellular carcinoma (HCC) and pulmonary oligometastasis, it remains unclear whether metastatectomy or stereotactic body radiation therapy (SBRT) is the more effective treatment for these patients. We aimed to compare the oncologic outcomes of metastasectomy and SBRT for HCC with pulmonary oligometastasis. METHODS AND MATERIALS: We retrospectively analyzed 209 patients with HCC with 322 metastatic lung lesions who underwent either metastasectomy (150 patients with 241 lesions) or SBRT (59 patients with 81 lesions) between January 2008 and December 2018. Propensity score-based inverse probability of treatment weighting was used to minimize potential bias between the 2 groups. RESULTS: The median follow-up duration was 39.8 months (range, 2.3-166.9 months). The 2-year rate of freedom from local progression was 98.2% in the metastasectomy group and 97.0% in the SBRT group (P = .197). The 2-year rates of overt systemic progression-free survival (PFS) (51.0% vs 46.1%; P = .274), PFS (26.3% vs 9.1%; P = .074), and overall survival (OS, 74.0% vs 57.6%; P = .006) were higher in the metastasectomy group. After the probability of treatment weighting adjustment, the 2-year rates of overt systemic PFS (50.8% vs 52.7%; P = .396), PFS (23.0% vs 24.7%; P = .478), and OS (72.6% vs 83.0%, P = .428) were not significantly different between the 2 groups. In multivariate analysis, viable intrahepatic lesions and the number of prior liver-directed therapies were found to be significant prognostic factors for OS and PFS. The time interval between HCC diagnosis and the development of pulmonary metastases was also significantly associated with OS. CONCLUSIONS: Both metastasectomy and SBRT demonstrated excellent local control and comparable oncologic outcomes in patients with pulmonary oligometastasis from HCC. The treatment modality for these patients could be determined based on the individual patient's condition and intrahepatic disease status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology.
- Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: geundy@hanmail.net.
- Department of Radiation Oncology. Electronic address: drsmyoon@amc.seoul.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Shin, Y. S., Yun, J. K., Jung, J., Park, J. H., Song, S. Y., Choi, E. K., Choi, S., Kim, H. R., Kim, Y. H., Kim, D. K., Lee, G. D., & Yoon, S. M. (2025). Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis. International Journal of Radiation Oncology*Biology*Physics, 121(2), 432-441. https://doi.org/10.1016/j.ijrobp.2024.09.022
Vancouver
Shin YS, Yun JK, Jung J, Park JH, Song SY, Choi EK, et al. Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis. International Journal of Radiation Oncology*Biology*Physics. 2025;121(2):432-441. doi:10.1016/j.ijrobp.2024.09.022
BibTeX
@article{Shin2025,
author = {Shin, Young Seob and Yun, Jae Kwang and Jung, Jinhong and Park, Jin-Hong and Song, Si Yeol and Choi, Eun Kyung and Choi, Sehoon and Kim, Hyeong Ryul and Kim, Yong-Hee and Kim, Dong Kwan and Lee, Geun Dong and Yoon, Sang Min},
title = {Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
volume = {121},
number = {2},
pages = {432--441},
doi = {10.1016/j.ijrobp.2024.09.022}
}
EUVIMED